Alzheimers Disease Concept , Brain Degenerative Diseases Parkins

U.S. Congress Approves the BOLD Infrastructure for Alzheimer’s Act

The Building Our Largest Dementia (BOLD) Infrastructure for Alzheimer’s Act is the latest attempt by the federal government to address the growing health crisis that is Alzheimer’s disease. Currently, Alzheimer’s costs more to treat than any other disease in the country at an estimated $277 billion in 2018 alone, including $186 billion in Medicare and Medicaid costs.

Continue Reading

Why An eMAR?

A MAR, or Medical Administration Record, is a legal record of drugs administered to a patient by a healthcare professional. Healthcare providers transitioning to an electronic MAR are choosing a better way of providing care for their patients as efficiently as possible.

Continue Reading

Managing Key Medicines: Antibiotic Stewardship Programs In Skilled Nursing Homes

Antibiotic overuse is a classic example of “too much of a good thing.” These medicines protect us against a multitude of bacterial illnesses, expanding human lifespans and allowing us to carry out a range of activities without fear. But when people take too many antibiotics, or take them for the wrong illnesses, they harm their own health while making the drugs less effective for everyone.

Continue Reading

Treatment Termination: What Happens When You Stop Taking Your Medications?

Picture “prescription drug problem” and you probably imagine people taking medications they don’t need. But our society also has the opposite problem— many people fail to take medications that they very much need! A staggering 125,000 Americans die each year from failing to take essential medicine, while millions more become seriously ill. It is thus essential that we all take essential medications consistently and make sure our loved ones do as well. But that starts with figuring out why people stop taking medications and what the consequences are of doing so:

Continue Reading